首页> 外文期刊>Pediatric blood & cancer >Duration of the Pre-Diagnostic Interval in Medulloblastoma is Subgroup Dependent
【24h】

Duration of the Pre-Diagnostic Interval in Medulloblastoma is Subgroup Dependent

机译:髓母细胞瘤诊断前间隔的持续时间取决于亚组

获取原文
获取原文并翻译 | 示例
           

摘要

Background The introduction of multimodal therapy has improved the survival rate of bilateral Wilms tumors (BWT); however, the results are still not satisfactory in terms of the renal preservation. To establish a new treatment strategy for BWT, we reviewed the results of the cases registered in the Japan Wilms Tumor Study Group (JWiTS). Procedure This analysis concerned patients with synchronous BWT registered in the JWiTS between 1996 and 2011. In these patients, the management of BWT included initial tumor resection or biopsy followed by chemotherapy. The details of the treatments and outcomes were analyzed. Results Among the 355 cases registered in the JWiTS database, 31 (8.7%) had BWT. They were 16 males and 15 females with a mean age of 15.5 months. Preoperative chemotherapy was performed in 24 cases. Bilateral nephron-sparing surgery (NSS) was achieved in 10 of 28 cases (36%). All of the cases were of favorable nephroblastoma without anaplasia, and a WT1 mutation was detected in 21 of the 27 cases (78%) examined. The 5-year overall survival was 92.6%; however, 10 children (40%) developed impaired renal function and three of them developed renal failure. Conclusions The long-term survival rates for patients with synchronous BWT have improved. However, more than half of patients receive nephrectomy. The protocol should be changed to improve the rate of preservation of the renal parenchyma. Preoperative chemotherapy should be performed to shrink the tumors in every case, and subsequent NSS should be carried out after a central imaging evaluation. Pediatr Blood Cancer 2014;61:1184-1189. (c) 2014 Wiley Periodicals, Inc.
机译:背景技术多模式疗法的引入提高了双侧Wilms肿瘤(BWT)的生存率。然而,就肾脏保存而言,结果仍不令人满意。为了建立针对BWT的新治疗策略,我们回顾了在日本Wilms肿瘤研究小组(JWiTS)中注册的病例的结果。程序该分析涉及1996年至2011年在JWiTS中注册的同步BWT患者。在这些患者中,BWT的管理包括最初的肿瘤切除或活检,然后进行化疗。分析了治疗的细节和结果。结果在JWiTS数据库中登记的355例病例中,有31例(8.7%)患有BWT。他们是男16例,女15例,平均年龄为15.5个月。术前化疗24例。 28例中有10例(36%)实现了双侧保留肾单位的手术(NSS)。所有病例均为无发育不良的有利肾母细胞瘤,在检查的27例病例中有21例(78%)检测到WT1突变。 5年总生存率为92.6%;但是,有10名儿童(40%)肾功能受损,其中3名患有肾功能衰竭。结论同步BWT患者的长期生存率有所提高。但是,超过一半的患者接受了肾切除术。应该改变方案以提高肾实质的保存率。在每种情况下,均应进行术前化疗以缩小肿瘤,并应在中央影像学评估后进行随后的NSS。小儿血液癌2014; 61:1184-1189。 (c)2014年威利期刊有限公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号